Comparative performance of QuantiFERON-TB ® Gold versus skin test with tuberculosis recombinant allergen (Diaskintest®) among patients with suspected pulmonary tuberculosis in Russia

Tuberculosis (TB) is one of the top ten causes of death worldwide and the primary cause of death due to any single infectious agent. In 2017, approximately 10 million people developed TB, and 1.3 million died from the disease (WHO 2018). According to a recent estimate, approximately 1.7 billion people have latent TB infection (LTBI, (RMGJ and Dodd, 2016)) which can be progress to active TB during the lifetime. As long as individuals with LTBI exist, TB elimination will not be feasible (ECDC 2018).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research